May 7th 2024
In patients with Clostridium difficile infection (CDI), ibezapolstat was shown to have similar results to a standard of care therapy.
Can Fidaxomicin Provide Effective C difficile-Associated Diarrhea Prophylaxis for HSCT Recipients?
March 18th 2019Clostridium difficile rates in stem cell transplant patients are approximately 9 times greater than in hospitalized patients, with rates about twice as high in allogeneic vs autologous transplants.
Read More
C Difficile Infection 2 Years Later: Even Nonelderly Patients Vulnerable to GI Symptoms
February 4th 2019The long-term health care burden after Clostridium difficile (C diff) infection (CDI) is great for elderly patients. But even nonelderly patients are at risk for gastrointestinal symptoms for up to 2 years afterward.
Read More
Metronidazole Comparable to Vancomycin for Mild C Diff Infections
December 26th 2018In a new study, researchers with the US Department of Veterans Affairs found that metronidazole is as effective as vancomycin for treating mild cases of Clostridium difficile infection, despite new guidelines no longer recommending metronidazole.
Read More